Return to homepagePandemic Pact

Development of a phenotypic screening platform for drug repositioning, discovery of new chemical entities and validation of targets for treatment of COVID-19

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    University of São Paulo

  • Principal Investigator

    Unspecified Unspecified Unspecified

  • Research Location

    Brazil

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This initiative consists of using human cell cultures infected with the SARS-CoV-2 coronavirus and evaluating the antiviral activity of different molecules, both synthetic and natural. This initiative is developed in the biosafety level 3 laboratory (NB3) of the Microbiology Department at ICB-USP.